Department of Obstetrics and Gynaecology, West China Second University Hospital of Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
BJOG. 2023 Jan;130(2):176-183. doi: 10.1111/1471-0528.17339. Epub 2022 Nov 13.
Minimally invasive radical hysterectomy has been reported to increase the risk of cancer relapse and death compared with open surgery in women with early-stage cervical cancer. The use of a uterine manipulator is considered one of the risk factors.
To investigate whether women with early-stage cervical cancer treated with minimally invasive radical hysterectomy without using uterine manipulator have oncological outcomes similar to those of open surgery.
Searches were performed in MEDLINE, Embase and CENTRAL from their inception until 31 March 2022.
Inclusion criteria were: (1) randomised controlled trials or observational cohort studies published in English, (2) studies comparing minimally invasive radical hysterectomy without using a uterine manipulator with open radical hysterectomy in women with early-stage cervical cancer, and (3) studies comparing survival outcomes.
Two authors independently conducted data extraction and assessed study quality. We calculated the hazard ratios (HR) and the 95% confidence intervals (CI) using the inverse variance approach for survival outcome.
Six observational studies with 2150 women were included. The minimally invasive surgery group had a significantly higher risk of cancer relapse compared with open surgery group (HR 1.55, 95% CI 1.15-2.10).
Minimally invasive radical hysterectomy without using a uterine manipulator resulted in an inferior recurrence-free survival compared with open radical hysterectomy in the treatment of women with early-stage cervical cancer.
与开腹手术相比,早期宫颈癌患者行微创根治性子宫切除术已被报道增加癌症复发和死亡的风险。使用子宫操纵器被认为是其中一个危险因素。
研究在早期宫颈癌患者中采用无子宫操纵器的微创根治性子宫切除术是否具有与开腹手术相似的肿瘤学结局。
在 MEDLINE、Embase 和 CENTRAL 数据库中进行了检索,检索时间截至 2022 年 3 月 31 日。
纳入标准为:(1)发表于英文期刊的随机对照试验或观察性队列研究;(2)比较无子宫操纵器的微创根治性子宫切除术与早期宫颈癌患者开腹根治性子宫切除术的研究;(3)比较生存结局的研究。
两名作者独立进行数据提取和研究质量评估。我们采用逆方差法计算生存结局的风险比(HR)和 95%置信区间(CI)。
纳入了 6 项包含 2150 名女性的观察性研究。微创组的癌症复发风险明显高于开腹组(HR 1.55,95% CI 1.15-2.10)。
在治疗早期宫颈癌患者时,与开腹根治性子宫切除术相比,无子宫操纵器的微创根治性子宫切除术导致无复发生存率降低。